Application of a Persistent Heparin Treatment Inhibits the Malignant Potential of Oral Squamous Carcinoma Cells Induced by Tumor Cell-Derived Exosomes
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Exosomes are 30-100 nm-sized membranous vesicles, secreted from a variety of cell types into their surrounding extracellular space. Various exosome components including lipids, proteins, and nucleic acids are transferred to recipient cells and affect their function and activity. Numerous studies have showed that tumor cell-derived exosomes play important roles in tumor growth and progression. However, the effect of exosomes released from oral squamous cell carcinoma (OSCC) into the tumor microenvironment remains unclear. In the present study, we isolated exosomes from OSCC cells and investigated the influence of OSCC cell-derived exosomes on the tumor cell behavior associated with tumor development. We demonstrated that OSCC cell-derived exosomes were taken up by OSCC cells themselves and significantly promoted proliferation, migration, and invasion through the activation of the PI3K/Akt, MAPK/ERK, and JNK-1/2 pathways in vitro. These effects of OSCC cell-derived exosomes were obviously attenuated by treatment with PI3K, ERK-1/2, and JNK-1/2 pharmacological inhibitors. Furthermore, the growth rate of tumor xenografts implanted into nude mice was promoted by treatment with OSCC cell-derived exosomes. The uptake of exosomes by OSCC cells and subsequent tumor progression was abrogated in the presence of heparin. Taken together, these data suggest that OSCC cell-derived exosomes might be a novel therapeutic target and the use of heparin to inhibit the uptake of OSCC-derived exosomes by OSCC cells may be useful for treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sento et al. reported that heparin may suppress metastasis by lessening the uptake of exosomes, derived from cancer cells in oral squamous cell carcinoma [185].”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [185]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
Taylor, D. D., & Gercel-Taylor, C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.04.033 · Cited by 2,288
RetractedJemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Extracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099 · cited 1×
“Exosomes, which are small membrane vesicles that originate from multi-vesicular bodies, 30–100 nm in diameter, are released by a variety of mammalian cells into the extracellular space and are taken up by recipient cells [2, 3].”
BackgroundMelanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2753 · Cited by 3,715
Johnstone, R. M., Adam, M., Hammond, J. R., Orr, L., & Turbide, C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48095-7 · Cited by 2,931
Routes and mechanisms of extracellular vesicle uptake
Mulcahy, L. A., Pink, R. C., & Carter, D. R. F. (2014) · Journal of Extracellular Vesicles · doi:10.3402/jev.v3.24641 · Cited by 2,832 · cited 4×
“In addition, western blot analysis demonstrated that tetraspanins CD9 and CD63, Rab5B, and Annexin II which are used markers for exosomes, were expressed on OSC-3 and OSC-4 cell-derived exosomes.”
BackgroundInfluentialRab27a and Rab27b control different steps of the exosome secretion pathway
Ostrowski, M., Carmo, N. B., Krumeich, S., Fanget, I., Raposo, G., Savina, A., Moita, C. F., Schauer, K., Hume, A. N., Freitas, R. P., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2000 · Cited by 2,750 · cited 1×
“Recently, the small GTPase Rab27a and a syndecan-syntenin-ALIX-mediated pathway were reported to regulate exosomal biogenesis and secretion [21, 44, 45].”
BackgroundExosomes: Extracellular organelles important in intercellular communication
Mathivanan, S., Ji, H., & Simpson, R. J. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.06.006 · Cited by 2,537 · cited 1×
“Exosomes contain lipids, proteins, and nucleic acids from their cell of origin, which are transferred to recipient cells and affect their function and activity [4].”
BackgroundVlassov, A. V., Magdaleno, S., Setterquist, R., & Conrad, R. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.03.017 · Cited by 1,930 · cited 1×
“Exosomes, which are small membrane vesicles that originate from multi-vesicular bodies, 30–100 nm in diameter, are released by a variety of mammalian cells into the extracellular space and are taken up by recipient cells [2, 3].”
Background
Cited by
Tumor microenvironment complexity and therapeutic implications at a glance
Baghban, R., Roshangar, L., Jahanban-Esfahlan, R., Seidi, K., Ebrahimi-Kalan, A., Jaymand, M., Kolahian, S., Javaheri, T., & Zare, P. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0530-4 · Cited by 1,784
“reported that heparin may suppress metastasis by lessening the uptake of exosomes, derived from cancer cells in oral squamous cell carcinoma [185] .”
BackgroundExosome-Mediated Metastasis: Communication from a Distance
Wortzel, I., Dror, S., Kenific, C. M., & Lyden, D. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.04.011 · Cited by 1,285
Li, X., Corbett, A. L., Taatizadeh, E., Tasnim, N., Little, J. P., Garnis, C., Daugaard, M., Guns, E., Hoorfar, M., & Li, I. T. S. (2019) · APL Bioengineering · doi:10.1063/1.5087122 · Cited by 564
Syn, N., Wang, L., Sethi, G., Thiery, J.-P., & Goh, B.-C. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.04.006 · Cited by 478
Exosomes: Small vesicles with big roles in cancer, vaccine development, and therapeutics
Thakur, A., Parra, D. C., Motallebnejad, P., Brocchi, M., & Chen, H. J. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.08.029 · Cited by 224
“Oral squamous cancer metastasis has been reported to be blocked by reducing exosome uptake via heparin [115].”
BackgroundInsight into Extracellular Vesicle-Cell Communication: From Cell Recognition to Intracellular Fate
Ginini, L., Billan, S., Fridman, E., & Gil, Z. (2022) · Cells · doi:10.3390/cells11091375 · Cited by 176
Exosomes: Current use and future applications
Chung, I., Rajakumar, G., Venkidasamy, B., Subramanian, U., & Thiruvengadam, M. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.10.022 · Cited by 169
Glaviano, A., Lau, H., Carter, L. M., Lee, E. H. C., Lam, H. Y., Okina, E., Tan, D. J. J., Tan, W., Ang, H. L., Carbone, D., et al. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01634-6 · Cited by 183
Emerging roles and therapeutic value of exosomes in cancer metastasis
Wu, M., Wang, G., Hu, W., Yao, Y., & Yu, X.-F. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0964-8 · Cited by 140
“have found that heparin can remarkably block metastasis by decreasing uptake of tumor-derived exosomes in oral squamous carcinoma [94].”
BackgroundExtracellular vesicles and particles impact the systemic landscape of cancer
Lucotti, S., Kenific, C. M., Zhang, H., & Lyden, D. C. (2022) · The EMBO Journal · doi:10.15252/embj.2021109288 · Cited by 155
Matsumoto, A., Takahashi, Y., Nishikawa, M., Sano, K., Morishita, M., Charoenviriyakul, C., Saji, H., & Takakura, Y. (2017) · Cancer Science · doi:10.1111/cas.13310 · Cited by 133
Martins, Á. M., Ramos, C. C., Freitas, D., & Reis, C. A. (2021) · Cells · doi:10.3390/cells10010109 · Cited by 127
“Interestingly, the use of heparanase inhibitors showed to block tumor progression by reducing exosome uptake by receptor cells [11,182,183].”
BackgroundStrategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy
Hussen, B. M., Faraj, G. S. H., Rasul, M. F., Hidayat, H. J., Salihi, A. B., Baniahmad, A., Taheri, M. N., & Ghafouri‐Fard, S. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02743-3 · Cited by 115
Role of tumor-derived exosomes in cancer metastasis
Wee, I. J. Y., Syn, N. L. X., Sethi, G., Goh, B. C., & Wang, L. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.10.004 · Cited by 113
Xie, C., Ji, N., Tang, Z., Li, J., & Chen, Q. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0985-3 · Cited by 107
“demonstrated that OSCC-derived exosomes can self-uptake or become absorbed by surrounding tumor cells and then accelerate cell proliferation and invasion by activating AKT, MAPK/ ERK, and JNK signaling pathways [72].”
BackgroundZorrilla, S. R., Pérez‐Sayáns, M., Fais, S., Logozzi, M., Gallas, M., & García, A. G. (2019) · Cancers · doi:10.3390/cancers11030429 · Cited by 109
“Oral Squamous Cell Carcinoma (OSCC)-derived exosomes are taken up by OSCC cells themselves and significantly promote proliferation, migration and invasion [29].”
BackgroundBerenguer, J., Lagerweij, T., Zhao, X. W., Dusoswa, S. A., van der Stoop, P. P. M., Westerman, B. A., de Gooijer, M. C., Zoetemelk, M., Zomer, A., Crommentuijn, M. H. W., et al. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1446660 · Cited by 105
Potential roles and prognostic significance of exosomes in cancer drug resistance
Mostafazadeh, M., Samadi, N., Kahroba, H., Baradaran, B., Haiaty, S., & Nouri, M. (2021) · Cell & Bioscience · doi:10.1186/s13578-020-00515-y · Cited by 98
“Pretreatment of oral squamous carcinoma cells (OSCCs) with heparin, a competitive inhibitor of HSPG mediated endocytosis, inhibits exosome uptake by recipient cells and suppresses the exosome induced tumor progression in vitro and in vivo [104].”
BackgroundLi, X., Liu, J., Fan, L., Liu, Y., Cheng, L., Wang, F., Yu, H., Gao, J., Wei, W., Wang, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8358 · Cited by 94
“Exosomes secreted by tumor cells are thought to package tumor-specific molecules, and promote tumor cell proliferation under various conditions, and this hypothesis has been verified by a number of studies [23, 24].”
BackgroundRole of JNK signaling in oral cancer: A mini review
Gkouveris, I., & Nikitakis, N. G. (2017) · Tumor Biology · doi:10.1177/1010428317711659 · Cited by 87
Autophagy modulators for the treatment of oral and esophageal squamous cell carcinomas
Khan, T., Relitti, N., Brindisi, M., Magnano, S., Zisterer, D. M., Gemma, S., Butini, S., & Campiani, G. (2019) · Medicinal Research Reviews · doi:10.1002/med.21646 · Cited by 90
“The uptake of exosomes by the OSCC cells and the successive tumor progression was decreased in the presence of heparin, an inhibitor of cell surface proteoglycan receptors.(334) OSCC exosomes exhibited significantly increased CD63 surface densities and demonstrated irregular morphologies.”
BackgroundExosomes impact survival to radiation exposure in cell line models of nervous system cancer
Mrowczynski, O., Madhankumar, A. B., Sundstrom, J. M., Zhao, Y., Kawasawa, Y. I., Slagle‐Webb, B., Mau, C. Y., Payne, R. A., Rizk, E., Zacharia, B. E., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26300 · Cited by 81
“The use of antibodies to the CD81 protein on the cell surface of exosomes as well as using heparin, and simvastatin to block exosome uptake are just beginning to be investigated [32, 33, 34, 35, 36, 37].”
BackgroundFrom Exosome Biogenesis to Absorption: Key Takeaways for Cancer Research
Lau, N. C. H., & Yam, J. W. P. (2023) · Cancers · doi:10.3390/cancers15071992 · Cited by 93
The Emerging Role of Exosomes in Diagnosis, Prognosis, and Therapy in Head and Neck Cancer
Hofmann, L., Ludwig, S., Vahl, J. M., Brunner, C., Hoffmann, T. K., & Theodoraki, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114072 · Cited by 79
“Early studies with xenograft tumor models showed that OSCC cell-derived exosomes promoted tumor growth in vivo [43].”
BackgroundExosomes in Head and Neck Squamous Cell Carcinoma
Cheng, X., Song, F., Zheng, Y., Lv, J., Wang, Q. F., & Xu, N. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00894 · Cited by 66
“Treatment with heparin blocks the uptake of exosomes by oral SCC cells, thereby attenuating exosome-induced cancer progression to inhibit the growth and progression of oral SCC cells (20).”
BackgroundPotential Markers from Serum-Purified Exosomes for Detecting Oral Squamous Cell Carcinoma Metastasis
Li, C., Zhou, Y., Liu, J., Su, X., Qin, H., Huang, S.-H., Huang, X., & Zhou, N. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-1122 · Cited by 64
“Previous research has examined exosomes isolated from OSCC cells (3, 31, 32); however, there was no study measuring the differences in protein expression levels in SEs from serum using proteomics, especially with samples from OSCC with LNM patients.”
Extracellular Vesicles and Their Roles in the Tumor Immune Microenvironment
Reale, A., Khong, T. T., & Spencer, A. G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11236892 · Cited by 64
Current Status, Opportunities, and Challenges of Exosomes in Oral Cancer Diagnosis and Treatment
Liu, H., Huang, Y., Huang, M., Huang, Z., Wang, Q., Qing, L., Li, L., Xu, S., & Jia, B. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s365594 · Cited by 57
Dilsiz, N. (2021) · Future Science OA · doi:10.2144/fsoa-2021-0102 · Cited by 58
“Exosomes derived from bladder cancer and oral squamous carcinoma cells have also been shown that the activated PI3K/AKT and MAPK/ERK pathways stimulate cell proliferation [68,69].”
BackgroundExosomes and other extracellular vesicles in oral and salivary gland cancers
Zhan, C., Yang, X., Yin, X., & Hou, J. L. (2019) · Oral Diseases · doi:10.1111/odi.13172 · Cited by 52
Wang, X., Guo, J., Yu, P., Guo, L., Mao, X., Wang, J., Miao, S., & Sun, J. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01840-x · Cited by 52
Yamana, K., Inoue, J., Yoshida, R., Sakata, J., Nakashima, H., Arita, H., Kawaguchi, S., Gohara, S., Nagao, Y., Takeshita, H., et al. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12169 · Cited by 47
“In OSCC, EVs derived from OSCC cells or the surrounding stromal cells are associated with tumour growth, infiltration, and metastasis (Sento et al., 2016; Xie et al., 2019).”
BackgroundSignaling of Tumor-Derived sEV Impacts Melanoma Progression
Zebrowska, A., Widlak, P., Whiteside, T. L., & Pietrowska, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145066 · Cited by 44
Cancer-derived exosomes as novel biomarkers in metastatic gastrointestinal cancer
Zhong, D., Wang, Z., Ye, Z., Wang, Y., & Cai, X. (2024) · Molecular Cancer · doi:10.1186/s12943-024-01948-6 · Cited by 47
“Sento et al. reported that heparin can remarkably decrease the uptake of CDEs to abro-gate tumor progression and metastasis [182].”
BackgroundSasabe, E., Tomomura, A., Liu, H., Sento, S., Kitamura, N., & Yamamoto, T. (2021) · Cancer Science · doi:10.1111/cas.15225 · Cited by 36
Self-citationEffects of glioblastoma-derived extracellular vesicles on the functions of immune cells
Musatova, O. E., & Rubtsov, Y. P. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1060000 · Cited by 42
Overcoming Chemoresistance via Extracellular Vesicle Inhibition
Hayatudin, R., Fong, Z., Ming, L. C., Goh, B. H., Lee, W.-L., & Kifli, N. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.629874 · Cited by 37
Yap, T., Pruthi, N., Seers, C. A., Belobrov, S., McCullough, M. J., & Celentano, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041197 · Cited by 38
“Sento et al. 2016 [26], found that heparin treatment abrogated the uptake of OSCC-4 cell-derived exosomes by OSC-4 cells and subsequent effects such as promotion of cell proliferation, migration and invasion.”
BackgroundInfluentialExosomal microRNAs (exoMIRs): micromolecules with macro impact in oral cancer
Dhar, R., Mallik, S., & Devi, A. (2022) · 3 Biotech · doi:10.1007/s13205-022-03217-z · Cited by 36
Emerging functions and clinical applications of exosomes in human oral diseases
Peng, Q., Yang, J., & Zhou, G. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00424-0 · Cited by 44
Tumor‐derived exosomes enhance invasion and metastasis of salivary adenoid cystic carcinoma cells
Hou, J. L., Wang, F., Liu, X., Song, M., & Yin, X. (2017) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12654 · Cited by 30
“Tumor-derived exosomes (TDE) have been shown to induce the progression of their parental cells in vitro.(12) In the study, we investigated the effects of SACC cell-derived exosomes on the malignant potential of tumor cells.”
BackgroundGhoshal, B., Bertrand, É., & Bhattacharyya, S. N. (2021) · Journal of Cell Science · doi:10.1242/jcs.253914 · Cited by 34
Choi, J. U., Park, I., Lee, Y.-K., & Hwang, S. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197363 · Cited by 28
Tomita, R., Sasabe, E., Tomomura, A., & Yamamoto, T. (2020) · Oncology Reports · doi:10.3892/or.2020.7748 · Cited by 37
“These reports suggest that within the tumor microenvironment, exosomes secreted from the stromal cells, including those released from the TAMs, may also be involved in chemotherapy failure in OSCC (16-20).”
Self-citationQu, X., Li, J., Chan, J. Y. K., & Meehan, K. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218260 · Cited by 30
“This concept is supported by an earlier study that used heparin to suppress the internalization of CD9+/CD63+/Rab5+/Annexin II+ EVs from oral tongue cancer (OSC3 and OSC4) cells via masking heparin sulfate proteoglycans on cancer cell surfaces [127].”
ResultJangholi, A., Bark, J. M., Kenny, L., Vasani, S. S., Rao, S., Dolcetti, R., & Punyadeera, C. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188784 · Cited by 25
The uptake of extracellular vesicles: Research progress in cancer drug resistance and beyond
Qian, L., Chen, P., Zhang, S., Wang, Z., Guo, Y., Koutouratsas, V., Fleishman, J. S., Huang, C., & Zhang, S. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101209 · Cited by 22
Emerging roles of extracellular vesicles in oral and maxillofacial areas
Wang, Q., Sun, J., Jiang, H., & Yu, M. (2025) · International Journal of Oral Science · doi:10.1038/s41368-024-00341-9 · Cited by 25
de Andrade, A., de Oliveira, C., Dourado, M., Macedo, C., Winck, F. V., Leme, A. F. P., Salo, T. A., Coletta, R. D., Freitas, R. D. A., & Galvão, H. (2017) · Oral Diseases · doi:10.1111/odi.12765 · Cited by 20
“Sento, Sasabe, and Yamamoto (2016) have revealed that oral squamous cell carcinoma (OSCC) cells- derived EVs promoted neoplastic growth and expansion, nonetheless, the events triggered by these vesicles on endothelial cells are still incompletely understood.”
Lee, K., Lee, J., Lee, P., Kim, C.-U., Kim, D., Jeong, Y., Park, Y., Tesh, V. L., & Lee, M. (2020) · Cellular Microbiology · doi:10.1111/cmi.13249 · Cited by 20
Serum exosome-derived biomarkers for the early detection of oral squamous cell carcinoma
Guo, H., Jiang, W., Huang, S.-H., Huang, X., & Li, C. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04254-7 · Cited by 19
Role of exosomes in the communication and treatment between OSCC and normal cells
Ma, X., Yang, R., Li, H., Zhang, X., Zhang, X., & Li, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28148 · Cited by 26
“For example, Sento et al. found that OSCC cells can take up exosomes secreted by donor OSCC cells; however, heparin can inhibit this process [44].”
BackgroundExosomes in head and neck cancer. Updating and revisiting
Zorrilla, S. R., García, A. G., Carrión, A. B., Vila, P. G., Martín, J. M. S., Gallas, M., & Pérez‐Sayáns, M. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2019.1662000 · Cited by 20
Traberg, W. C., Uribe, J., Druet, V., Hama, A., Moysidou, C., Huerta, M., McCoy, R. S. A., Hayward, D., Savva, A., Genovese, A. M. R., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202301194 · Cited by 14
Robin, H. P., Trudeau, C., Robbins, A. J., Chung, E. J., Rahman, E., Strickland, O. L. G., Scott, J., Licari, F. W., Winden, D. R., Reynolds, P. R., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.917862 · Cited by 18
“activation of these MAP kinase members has been demonstrated in enhancing proliferation and migration of OSCCs (29).”
BackgroundPang, H., Liu, L., Sun, X., Xi, W., Bao, Y., Wu, L., Shan, J., Wang, Z., Guo, Y., & Zhao, C. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153454 · Cited by 13
Starska, K. (2025) · Biology · doi:10.3390/biology14070852 · Cited by 12
Yu, W., Li, S., Zhang, G., Xu, H. H. K., Zhang, K., & Bai, Y. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1023700 · Cited by 13
Applications of Exosome Vesicles in Different Cancer Types as Biomarkers
Ihlamur, M., Kelleci, K., Zengin, Y., Allahverdiyev, A., & Abamor, E. Ş. (2023) · Current Molecular Medicine · doi:10.2174/1566524023666230320120419 · Cited by 16
Aquino, A., & Franzese, O. (2025) · Cancers · doi:10.3390/cancers17091547 · Cited by 13
“Exosome-targeting strategies to block EMT in various cancer models include proton pump inhibitors [395], Rab27a silencing [396,397], and heparin to inhibit uptake [398], although clinical data are limited.”
Exosomes and immune modulation: implications for neuroblastoma immunotherapy
Morini, M., Vitale, C., Ardito, M., Dondero, A., Cortese, K., Bottino, C., & Castriconi, R. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1600062 · Cited by 12
Himes, B. T., Fain, C. E., Tritz, Z. P., Nesvick, C. L., Jin‐Lee, H. J., Geiger, P. A., Peterson, T. E., Jung, M.-Y., & Parney, I. F. (2022) · Journal of neurosurgery · doi:10.3171/2022.6.jns2274 · Cited by 11
Bottino, L. Z. M. F., Rodrigues‐Junior, D. M., de Farias, I. S., Branco, L. M., Iyer, N. G., de Albuquerque, G. E., Vettore, A. L., & Bortoluci, K. R. (2021) · Current Research in Immunology · doi:10.1016/j.crimmu.2021.10.005 · Cited by 11
“, 2018) and metastasis (Sento et al., 2016; Li et al., 2018), and inducing M1-like polarization of tumor-associated macrophages (Chen et al.”
BackgroundJhaveri, J. R., Khare, P., Pinky, P. P., Kamte, Y. S., Chandwani, M. N., Milošević, J., Abraham, N., Sun, M., Stolz, D. B., Dave, K. M., et al. (2024) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114500 · Cited by 15
Important players in carcinogenesis as potential targets in cancer therapy: an update
Hermanowicz, J. M., Kwiatkowska, I., & Pawlak, D. (2020) · Oncotarget · doi:10.18632/oncotarget.27689 · Cited by 9
Molodtsova, D., Guryev, D. V., & Osipov, A. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216498 · Cited by 9
“The administration of exosome inhibitors heparin and simvastatin can help alleviate the detrimental effects of the oncosome injection derived from resistant cells in mice [23,111].”
BackgroundIpinmoroti, A. O., Pandit, R., Crenshaw, B. J., Sims, B., & Matthews, Q. L. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16655 · Cited by 7
“Along these same lines, a study in 2016 showed that exosome levels in squamous carcinoma OSC-4 cells were suppressed by 10 μg/mL heparin treatment [22].”
ResultAlkafaas, S. S., Khedr, S. A., Elkafas, S. S., Hafez, W., Loutfy, S. A., Sakran, M. I., & Janković, N. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107776 · Cited by 8
Hu, Y., Liu, X., Huang, Z., He, Z., Meng, Q., & Wang, X. (2019) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_150_18 · Cited by 7
Xu, Z., Jiang, P., & He, S. (2019) · Medical Science Monitor · doi:10.12659/msm.917736 · Cited by 7
“for OSCC early therapy or control [26,27].”
The Microenvironment of Tongue Cancer
Tao, W., Li-Juan, Z., Li, K., Jing-yuan, L., Liu, X., & Liang, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-59038-3_4 · Cited by 6
Mohamed, M. F., Al‐Khudari, S., Vieira, P. C., Erra, A., Bagabas, R., Houser, T. K., Stenson, K. M., Bhayani, M. K., Jelinek, M. J., Bishehsari, F., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-08905-7 · Cited by 5
Søland, T. M., Lipka, A., Ruus, A., Molværsmyr, A.-K., Galtung, H. K., & Haug, T. M. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1456346 · Cited by 5
Towards an emerging role for anticoagulants in cancer therapy: a systematic review and meta-analysis
Al‐Azzawi, H. M. A., Hamza, S. A., Paolini, R. A., Arshad, F., Patini, R., O’Reilly, L. A., McCullough, M. J., & Celentano, A. (2024) · Frontiers in Oral Health · doi:10.3389/froh.2024.1495942 · Cited by 4
[Adenoid cystic carcinoma cells produce exosomes that promote tumor cell proliferation].
Liu, X., Wang, F., Hou, J. L., Zhang, L., Chen, Z., & Yin, X. (2018) · Europe PMC (PubMed Central) · doi:10.3969/j.issn.1673-4254.2018.08.18 · Cited by 4
Potential effects of anticoagulants in preclinical mice models of oral cancer: A systematic review
Al‐Azzawi, H. M. A., Hamza, S. A., Lin, Z., Paolini, R. A., McCullough, M. J., Yap, T., & Celentano, A. (2023) · Oral Diseases · doi:10.1111/odi.14546 · Cited by 2
Effect of homotypic vs . heterotypic interactions on the cellular uptake of extracellular vesiclesPreprint
Jhaveri, J. R., Khare, P., Pinky, P. P., Kamte, Y. S., Chandwani, M. N., Milošević, J., Abraham, N., Dave, K. M., Zheng, S., O’Donnell, L. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.23.563628 · Cited by 2
Seki, Y., Yamana, K., Yoshida, R., Inoue, J., Shinohara, K., Oyama, T., Kubo, R., Nagata, M., Kawahara, K., Hirayama, M., et al. (2023) · Journal of Oral and Maxillofacial Surgery Medicine and Pathology · doi:10.1016/j.ajoms.2023.12.007 · Cited by 1
Alex, T. S., Lang, D. K., Zakir, F., Mirza, A., & Iqbal, Z. (2022) · Environmental chemistry for a sustainable world · doi:10.1007/978-3-031-14848-4_1 · Cited by 1
Human adenovirus type 3 restores pharmacologically inhibited exosomal cargo in lung carcinoma cells
Ipinmoroti, A. O., Pandit, R., Crenshaw, B. J., Sims, B., & Matthews, Q. L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1339862 · Cited by 2
“It was shown that Oral Squamous Cell Carcinoma (OSCC) treatment with Heparin inhibited exosome uptake by recipient cells including tumor growth induced by OSCC-derived exosomes (Sento et al., 2016).”
BackgroundEkici, Y., Tekkeşin, M. S., Küçüksezer, U. C., Celebioglu, H. B. O., Tuncer, E. B., Bedeloğlu, E., & Tuncer, F. N. (2024) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.13563 · Cited by 1
The Roles of Exosomes Related to Some Oral Diseases
Wang, S., Hu, H.-Z., Sun, G.-J., Jin, J., & He, X.-Y. (2018) · DEStech Transactions on Biology and Health · doi:10.12783/dtbh/icmsb2018/25429 · Cited by 1
“activation of the PI3K/Akt, MAPK/ERK, and JNK-1/2 pathways [46].”
BackgroundMitotherapy, an attractive avenue for the future medicine
Pourahmad, J., Handali, S., & Rezaei, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822416-8.00009-9 · Cited by 1
Exosomes: The Crucial Element in Prostate Cancer
Moulay, M., & Al-Kareem, S. (2020) · Springer eBooks · doi:10.1007/978-981-15-6599-1_15
Exosomes: Supramolecular Biomarker Conduit in Cancer
Kaur, M. P., & Sodhi, H. S. (2022) · Studies in computational intelligence · doi:10.1007/978-981-16-9221-5_18
Traberg, W. C., Uribe, J., Druet, V., Hama, A., Moysidou, C., Huerta, M., McCoy, R. S. A., Hayward, D., Savva, A., Genovese, A. M. R., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1697648/v1
Tumor Ecosystem-Directed Therapeutic Strategies
Saw, P. E., & Song, E. (2023) · Springer eBooks · doi:10.1007/978-981-99-1183-7_30
Sharma, V., Singh, S. B., Bandyopadhyay, S., Sikka, K., Kakkar, A., & Hariprasad, G. (2024) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2024.101842
“OSCC-derived exosomes promote tumor growth and metastasis by activating signaling pathways like PI3K/Akt and MAP-K/ERK through the secretion and uptake [54].”
BackgroundNon‐Anticoagulant Heparin: An In Vitro Investigation of a Novel Therapeutic Approach for Oral Cancer
Hamza, S. A., Paolini, R. A., O’brien-simpson, N. M., Singleton, W., Patini, R., McCullough, M. J., & Celentano, A. (2025) · Oral Diseases · doi:10.1111/odi.15288 · Cited by 2
“In fact, in terms of oral cancer, heparin has been studied with only limited interest in the literature (Kohei et al. 2009; Ling et al. 2022; Sento et al. 2016).”
Tegegne, B. A., Belew, H., Teffera, Z. H., Belayneh, M., Abebaw, D., Fikrie, M., Jemal, M., Baylie, T., Tadesse, F., Wondm, S. A., et al. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04396-y
“Heparin acts as a competitive inhibitor, binding to exosomes and preventing adhesion to cell surface HSPGs. Antibodies against surface proteins like tetherin can also interfere with exosome-cell interactions [127, 131, 132].”
Metadata
- Authors
- Sento, S., Sasabe, E., & Yamamoto, T.
- Affiliations
- University of Kochi (JP)
- Corresponding author
- Sento, Shinya
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-02-05
- Volume
- 11
- Issue
- 2
- Pages
- e0148454
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4743844
- OpenAlex
- W2259436158
- Cited by
- 91
- References
- 53
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 9 · 2023: 10 · 2022: 14 · 2021: 13 · 2020: 12 · 2019: 13 · 2018: 5 · 2017: 4 · 2016: 2
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Japan Society for the Promotion of Science (26670867)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Keywords
- oral squamous cell carcinoma, tumor-derived exosomes, heparin, exosome uptake, tumor progression, cell proliferation, cell migration and invasion, PI3K/Akt signaling, MAPK/ERK pathway, JNK signaling, tumor xenografts, therapeutic target
- MeSH terms
- Animals, Antineoplastic Agents, Carcinoma, Squamous Cell, Cell Movement, Heparin, Humans, Mice, Inbred BALB C, Mouth Neoplasms, Xenograft Model Antitumor Assays, Cell Line, Tumor, Extracellular Signal-Regulated MAP Kinases, Mitogen-Activated Protein Kinase 8, Mitogen-Activated Protein Kinase 9, Cell Proliferation, Proto-Oncogene Proteins c-akt, Exosomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.